Gunton James T. 5
5 · Cytosorbents Corp · Filed Feb 14, 2013
Insider Transaction Report
Form 5
Gunton James T.
Director
Transactions
- Award
Stock Options
2012-01-18+108,000→ 339,000 total(indirect: By Partnership)Exercise: $0.17From: 2012-01-18Exp: 2022-01-18→ Common Stock, par value $0.001 per share (108,000 underlying) - Award
Stock Options
2010-01-01+108,000→ 339,000 total(indirect: By Partnership)Exercise: $0.17From: 2010-01-01Exp: 2020-01-01→ Common Stock, par value $0.001 per share (108,000 underlying) - Award
Stock Options
2010-03-31+2,000→ 339,000 total(indirect: By Partnership)Exercise: $0.15From: 2010-03-31Exp: 2020-03-31→ Common Stock, par value $0.001 per share (2,000 underlying) - Award
Stock Options
2010-12-31+102,000→ 339,000 total(indirect: By Partnership)Exercise: $0.13From: 2010-12-31Exp: 2020-12-31→ Common Stock, par value $0.001 per share (102,000 underlying) - Award
Stock Options
2010-09-30+2,000→ 339,000 total(indirect: By Partnership)Exercise: $0.09From: 2010-09-30Exp: 2020-09-30→ Common Stock, par value $0.001 per share (2,000 underlying) - Award
Stock Options
2010-06-30+2,000→ 339,000 total(indirect: By Partnership)Exercise: $0.09From: 2010-06-30Exp: 2020-06-30→ Common Stock, par value $0.001 per share (2,000 underlying) - Conversion
Series B Convertible Preferred
2009-10-05$250000.00/sh+2,500$625,000,000→ 95,796,105 total(indirect: By Partnership)Exercise: $0.04→ Common Stock, par value $0.001 per share (6,906,077 underlying)
Footnotes (5)
- [F1]These Stock Options are held directly by NJTC Venture Fund SBIC, LP, of which the Reporting Person is a partner. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended or any other purpose.
- [F2]The stock options were issued as compensation for services rendered.
- [F3]Includes all of the options to purchase Common Stock by James Gunton, directly and indirectly. These include 15,000 option to purchase Common Stock by Jim Gunton reported on Form 4 filed with the SEC on January9, 2009.
- [F4]Immediately Exercisable.
- [F5]Not Applicable